(Q37832196)

24 August 2017

1 reference

title

Maternal autoantibodies and pregnancy--I: The antiphospholipid antibody syndrome (English)

1 reference

24 August 2017

1 reference

1

Harris EN

1 reference

24 August 2017

publication date

1 April 1990

1 reference

Bailliere's clinical rheumatology

24 August 2017

published in

1 reference

24 August 2017

volume

4

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

53-68

1 reference

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Antiphospholipid antibodies in early repeated abortions: a case-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Obstetric complications associated with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Spontaneous recurrent fetal wastage and autoimmune abnormalities: a study of fourteen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Subclinical autoimmune disease and unexplained abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Antibodies to phospholipids and nuclear antigens in patients with repeated abortions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Autoimmunity, fetal losses, lupus anticoagulant: beginning of systemic lupus erythematosus or new autoimmune entity with gynaeco-obstetrical expression?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Syndrome of the black swan

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

The Prosser-White oration 1983. Connective tissue disease and the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Anticardiolipin antibodies and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Anti-phospholipid antibody and pregnancy wastage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Lupus anticoagulant in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Fetal survival after prednisone suppression of maternal lupus-anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Subclinical autoimmunity in recurrent aborters

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

The natural history of systemic lupus erythematosus: An approach to its study through chronic biologic false positive reactors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Intrauterine death and circulating anticoagulant ("antithromboplastin")

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Fetal loss treatment in patients with antiphospholipid antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Intravenous gamma-globulin, antiphospholipid antibodies, and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Fetal death: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Antiphospholipid antibodies and recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980243-2

7 January 2021

10.1016/S0950-3579(05)80243-2

Identifiers

DOI

1 reference

24 August 2017

1 reference